Position in QURE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,922,124
+$27,337,299 QoQ
Shares Held
606,212
+2380.5% QoQ
Ownership
0.961%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#28
of 255 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Derivatives in QURE
reported options exposure · as of Mar 31, 2025CallValue
$2,120,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. QURE ranks #25 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in QURE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,922,124 | 606,212 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $584,825 | 24,439 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,830,766 | 254,082 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,476,789 | 105,939 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,378,795 | 130,075 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $2,120,000 | 200,000 | Call | Defined | 2025-07-21 | |
| 2024-12-31 | $31,282,076 | 1,771,352 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,816,082 | 976,893 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,003,537 | 224,004 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $963,164 | 185,224 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $234,000 | 45,000 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $6,304,799 | 931,285 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $274,942 | 40,975 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,586,980 | 313,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $23,038,347 | 1,143,910 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $37,923,056 | 1,672,830 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $79,915,461 | 4,259,886 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $71,199,208 | 3,819,700 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $58,732,921 | 3,250,300 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $40,764,884 | 1,965,520 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,400,560 | 856,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $57,740,760 | 1,874,700 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $64,339,915 | 1,909,763 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $17,643,471 | 488,333 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $33,872,919 | 919,710 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $49,339,167 | 1,094,966 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||